Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Etosys
- Development stage
- Phase 4
- Lead developer
- Systopic Laboratories
- Modality
- Small Molecules
- Administration
- Intramuscular, Intravenous, Oral
01
Overview
Etosys is a fixed-dose combination medication containing tranexamic acid and ethamsylate (also known as etamsylate), developed and marketed by Systopic Laboratories. It is primarily indicated for the treatment and management of heavy menstrual bleeding (menorrhagia/dysfunctional uterine bleeding) and other conditions involving excessive capillary or surgical blood loss. Tranexamic acid is an antifibrinolytic agent that prevents the breakdown of fibrin clots by competitively inhibiting plasminogen activation. Ethamsylate is a synthetic hemostatic agent that improves platelet adhesiveness and restores capillary wall resistance. Together, these two active ingredients work synergistically to promote clot stability and reduce blood loss.
- Brand names
- Etosys
- Other names
- etamsylate + tranexamic acidethamsylate + tranexamic acidtranexamic acid + etamsylatetranexamic acid + ethamsylate
02
Targets
PLG (Plasminogen)
Beyond the preview
Go deeper on Etosys.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Etosys.